Key facts
- This page summarizes GNI Group Ltd.'s Form 4 filing for CATALYST BIOSCIENCES, INC. (GYRE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Sep 2023, 16:07.
GNI Group Ltd. - 31 Aug 2023 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- GYRE
- Reported as of
- 31 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Sep 2023, 16:07:07 UTC
- Prior SEC filing
- 05 Jan 2023
- Next SEC filing
- 31 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Branden Berns, as attorney-in-fact for GNI Group Ltd.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
GNI Group Ltd. filed Form 4 for CATALYST BIOSCIENCES, INC. (GYRE) on 01 Sep 2023.
Change
- Previous filing in this sequence was filed on 05 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CBIO
transaction
Series Y Preferred Stock
Disposed to Issuer
- Transaction value
- Shares
- -895
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 31 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4
CBIO
transaction
Series Y Preferred Stock
Disposed to Issuer
- Transaction value
- Shares
- -5,371
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 31 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
On June 20, 2023, the Company's board of directors (the "Board") declared a dividend of one one-thousandth of a share of Series Y Preferred Stock, par value $0.001 per share (the "Preferred Stock"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on June 30, 2023, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on June 30, 2023. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company.
Footnote F2
On August 31, 2023, the Company filed, as approved by the Board, a certificate of elimination with the Secretary of State of the State of Delaware pursuant to which the outstanding shares of the Preferred Stock were eliminated.
Footnote F3
These securities are held by GNI Group Ltd. ("GNI Japan").
Footnote F4
GNI Hong Kong Ltd. ("GNI HK") disclaims beneficial ownership of the securities held by GNI Japan for purposes of Rule 16a-1(a)(2), except to the extent of its pecuniary interest therein.
Footnote F5
These securities are held by GNI HK.
Footnote F6
GNI HK, through GNI Japan-affiliated entities, is a wholly-owned subsidiary of GNI Japan. GNI Japan may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the securities held by GNI HK and, therefore, a "ten percent holder" hereunder.